Indeed, MCP-1 secretion from hepatocytes has also been demonstrated (19), but the relative contribution of hepatocyte-derived and NPC-derived MCP-1 to NASH pathogenesis, and the mechanisms underlying MCP-1 expression in hepatocytes, remain largely unknown. The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatohepatitis.